Safflower


Entry
D06717            Crude     Drug                                   
Name
Safflower (JP18);
Safflower (TN)
Component
Carthamin [CPD:C16941], Safflor yellow, Carthamidin [CPD:C16940], Neocarthamin [CPD:C17675], Lignan, Flavonoid [CPD:C01579], Sterol [CPD:C00370]
Source
Carthamus tinctorius [TAX:4222]
Remark
Therapeutic category: 5100
Product: D06717<JP>
Efficacy
Emmenagogue
Comment
Asteraceae (daisy family) Safflower petal
Major component: Carthamin [CPD:C16941]
Brite
Therapeutic category of drugs in Japan [BR:br08301]
 5  Crude drugs and Chinese medicine formulations
  51  Crude drugs
   510  Crude drugs
    5100  Crude drugs
     D06717  Safflower (JP18)
Classification of Japanese OTC drugs [BR:br08313]
 Drugs for women
  49 Drugs for women's health
   D06717  Safflower (JP18)
Risk category of Japanese OTC drugs [BR:br08312]
 Third-class OTC drugs
  Crude drugs
   Safflower
    D06717  Safflower (JP18)
Traditional Chinese Medicine in Japan [BR:br08304]
 Crude drugs
  Drugs for blood
   Drugs for removing blood stasis
    D06717  Safflower; Safflower
  Drugs for external use
   Drugs for external use
    D06717  Safflower; Safflower
Crude drugs [BR:br08305]
 Dicot plants: asterids
  Asteraceae (daisy family)
   D06717  Safflower
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
 Crude drugs
  D06717  Safflower
Other DBs
PubChem: 47208368